Luis Rivas Selected Research

Luis Rivas Research Topics

Disease

11	Leishmaniasis 03/2015 - 01/2005
9	Visceral Leishmaniasis (Kala Azar) 10/2022 - 04/2007
7	Infections 02/2020 - 12/2004
4	Cutaneous Leishmaniasis 10/2019 - 01/2004
3	Parasitic Diseases (Parasitic Disease) 01/2019 - 05/2009
3	Metaplasia 03/2016 - 02/2014
2	Dry Eye Syndromes (Dry Eye Syndrome) 09/2014 - 03/2003
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2010 - 10/2010
2	Malaria 12/2010 - 08/2009
1	Anisakiasis 10/2017
1	Hypersensitivity (Allergy) 10/2017
1	Inflammation (Inflammations) 09/2014
1	Cicatrix (Scar) 09/2014
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 09/2014
1	Limbal Stem Cell Deficiency 05/2012
1	Neglected Diseases 01/2012
1	Disease Progression 01/2012
1	Sepsis (Septicemia) 02/2011
1	Chagas Disease (American Trypanosomiasis) 08/2009
1	Amebiasis (Amoebiasis) 08/2009
1	Neoplasms (Cancer) 05/2009
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2009
1	Tics (Tic) 02/2009
1	Autolysis 05/2007
1	Hemoperitoneum 05/2006
1	False Aneurysm (Pseudoaneurysm) 05/2006
1	Lacerations 05/2006
1	Acinetobacter Infections 04/2006
1	Blepharospasm 03/2003

Drug/Important Bio-Agent (IBA)

10	miltefosine (Impavido)IBA 02/2020 - 10/2006
9	Pharmaceutical PreparationsIBA 10/2022 - 10/2006
3	Antimicrobial PeptidesIBA 01/2019 - 12/2004
3	Fluorescein (Funduscein)FDA LinkGeneric 09/2014 - 03/2003
3	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 07/2007 - 01/2004
2	liposomal amphotericin B FDA Link 10/2019 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 03/2015 - 07/2007
2	VaccinesIBA 01/2012 - 01/2005
2	8-aminoquinolineIBA 09/2011 - 12/2010
2	Colistin (Coly-Mycin)FDA Link 02/2011 - 04/2006
2	C-Type Lectins (C-Type Lectin)IBA 01/2005 - 01/2004
1	cyclobenzaprine FDA LinkGeneric 10/2022
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 02/2020
1	AntimonyIBA 10/2019
1	Antidepressive Agents (Antidepressants)IBA 12/2018
1	Sertraline (Zoloft)FDA LinkGeneric 12/2018
1	AllergensIBA 10/2017
1	GoldIBA 10/2017
1	5- chloro- 3- tert- butyl- 2'- chloro- 4'- nitrosalicylanilide (S 13)IBA 10/2017
1	trypanothione reductaseIBA 01/2017
1	Drug CombinationsIBA 12/2016
1	Sirtuin 1IBA 03/2015
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 04/2014
1	Hyaluronic Acid (Hyaluronan)IBA 02/2014
1	Coloring Agents (Dyes)IBA 02/2014
1	Rose BengalIBA 02/2014
1	Hematoxylin (Haematoxylon)IBA 05/2012
1	Periodic AcidIBA 05/2012
1	Messenger RNA (mRNA)IBA 05/2012
1	mCherry fluorescent proteinIBA 01/2012
1	Cytochromes c (Cytochrome c)IBA 12/2010
1	Primaquine FDA Link 12/2010
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 12/2010
1	tafenoquineIBA 12/2010
1	Oxidoreductases (Dehydrogenase)IBA 12/2010
1	IB-01212IBA 10/2010
1	Adenosine Monophosphate (AMP)IBA 08/2009
1	kahalalide FIBA 05/2009
1	DepsipeptidesIBA 05/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2009
1	Intercellular Adhesion Molecule-3IBA 07/2007
1	N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA 05/2007
1	Contrast MediaIBA 05/2006
1	Peptides (Polypeptides)IBA 04/2006
1	Lubricant Eye Drops (Artificial Tears)IBA 03/2003
1	SolutionsIBA 03/2003

Therapy/Procedure

4	Therapeutics 02/2020 - 01/2012
4	Drug Therapy (Chemotherapy) 08/2009 - 04/2006
1	Aftercare (After-Treatment) 03/2016
1	Transplantation 09/2014